Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Current Assets (2018 - 2025)

Historic Current Assets for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $56.0 million.

  • Bio's Current Assets rose 2700.08% to $56.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.0 million, marking a year-over-year increase of 2700.08%. This contributed to the annual value of $78.1 million for FY2024, which is 884.62% up from last year.
  • Latest data reveals that Bio reported Current Assets of $56.0 million as of Q3 2025, which was up 2700.08% from $60.7 million recorded in Q2 2025.
  • In the past 5 years, Bio's Current Assets ranged from a high of $89.2 million in Q2 2023 and a low of $44.1 million during Q3 2024
  • Moreover, its 5-year median value for Current Assets was $62.6 million (2024), whereas its average is $64.3 million.
  • As far as peak fluctuations go, Bio's Current Assets surged by 9539.82% in 2023, and later tumbled by 4634.54% in 2024.
  • Bio's Current Assets (Quarter) stood at $59.1 million in 2021, then grew by 5.74% to $62.4 million in 2022, then grew by 14.86% to $71.7 million in 2023, then increased by 8.85% to $78.1 million in 2024, then decreased by 28.21% to $56.0 million in 2025.
  • Its Current Assets stands at $56.0 million for Q3 2025, versus $60.7 million for Q2 2025 and $69.7 million for Q1 2025.